LicianPro

Camp4 Therapeutics Corp ·

CAMP 8-K 2026-09-28

Camp4 Therapeutics Corp (CAMP) 8-K dated 2026-09-28 — accession 0001628280-26-063740.

Camp4 Therapeutics Corp (CAMP) is a biotechnology company listed on NASDAQ.

Camp4 Therapeutics Corp filed a 8-K on 2026-09-28. Accession 0001628280-26-063740.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.

Not investment advice. The CAMP SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr